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ABSTRACT
ACT IMMUNOLOGICAL AND AUTOMATED CYTOLOGICAL 
ANALYSIS OE CHICKENS SELECTED EOR 
PROGRESSION OR REGRESSION OE ROUS 
SARCOMA VIRUS-INDUCED TUMORS
by
PAUL M. GUYRE 
Immunological and cytological comparisons were made 
of chickens genetically selected for progression or regres­
sion of Rons sarcoma virus (RSV)-induced tumors. Eg and E^
progeny chickens of the major histocompatibility complex (MHC)
2 2and B-blood group allotype B B usually regressed RSV-induced 
5 5tumors, while B-'B-' hosts almost invariably died of progressive 
2 2tumors. B B chickens were immune to secondary tumor formation
at 12 days following induction of a primary tumor; B^B^ animals
2 2were not. Thirty-three percent of B B birds with anti-tumor
immunity had detectable virus-neutralizing antibody at 12 days
post inoculation (PI). No neutralizing activity was found 
5 5m  sera from B-UEr hosts.
No significant difference in number of lymphocytes in 
circulating blood, or in stimulation of lymphocytes by the 
mitogens concanavalin A (con A) and phytohemagglutinin (PHA) 
was observed between the two genotypes.
A method was developed to preserve the fluorescence 
characteristics of acridine orange (AO) stained peripheral
ix
leukocytes for at least 5 days. Cytophotometric analysis of 
AO stained samples indicated that a subpopulation of peripheral 
leukocytes from animals with large tumors, regardless of B- 
haplotype, had an abnormally high intensity of red fluores­
cence. Since these leukocytes were non-adherent, agranulo­




THat genes of the major histocompatibility complex 
(MHC) are important regulators of immune responses is well 
established, (for a recent review, see Katz and Benacerraf,
1976). Early studies in mice linked genetic control of 
antibody production with the MHC (McDevitt and Sela, 1965), 
and recently, tumor development has been modified With products 
of MHC genes (Greene, Dorf, Pierres and Benacerraf, 1977)* In 
the chicken, the MHC is also known as the B-locus, since it 
includes genes which code for the B-erythrocyte antigens. The 
chicken B-locus has an influence on serum complement levels 
(Chahh., Benedict and Abplanalp, 1976), antibody production 
(Pevzner, Nordskog and Kaeberle, 1975; Benedict, Pollard,
Morrow, Abplanalp, Maurer and Briles, 1975)> and skin graft 
rejection (Shierman and Nordskog, 1961).
Collins et al. (1977) have shown that chickens with
2 2the homozygous B-genotype B B usually spontaneously regress
S 5RSV-induced tumors; B^B^ chickens, however, develop progressing 
tumors which result in early death of the animal. That an 
immune response (Ir) gene(s) residing in the chicken MHC might 
be responsible for the observed differences in tumor develop­
ment was proposed.
Additional studies have examined chickens with 
progressing or regressing tumors for differences in: a) migration
inhibition of macrophages (Cotter, 1973); t>) anti-tumor 
cytoxicity of lymphocytes (Archambault, 1976; McGrail, 1977); 
c) ultrastructure of lymphocytes and tumor cells (Archambault, 
1976); d) blocking of anti-tumor lymphocyte-mediated immunity 
by serum factors (McGrail, 1977); e) serum protein differences 
(Cucchiara, 1976); and f) lymphocyte differences following 
acridine orange-staining (Cucchiara, 1976).
Cucchiara (1976) observed a unique serum protein and 
red fluorescence of acridine orange-stained lymphocytes in 
samples from tumor-bearing, but not from tumor-free animals.
He concluded that the observed red fluorescence was due to 
ENA coating the lymphocyte surface since ENase treatment or 
repeated washing removed the red fluorescence, while DNase 
and protease had no effect.
The present study was undertaken to further delineate
the source of the red fluorescence and the function of red
fluorescing cells. Additional experiments compared anti-tumor
immunity, serum proteins, circulating lymphocyte density, and
2 2 5 5stimulation of lymphocytes by mitogens in B B vs. B-'B-' 
chickens.
CHAPTER II 
REVIEW OE THE LITERATURE 
THE ROLE OE THE MHC IN IMMUNOLOGICAL REACTIONS 
MOUSE
The major histocompatibility complex (MHC) is a group 
of closely linked genes which was first recognized for its 
control over acceptance or rejection of tissue allografts (for 
a review, see Klein, 1975)- While an MHC has been detected in 
all mammalian species studied (Paul and Benacerraf, 1977)? that 
of the mouse, called the H-2 complex, has been most thoroughly 
characterized. H-2 influence on antibody synthesis, mixed 
leukocyte reactions (MLR's), graft versus host reactions 
(GVHR's), anamnestic responses, delayed hypersensitivity and 
serum complement levels has been extensively documented 
(Shreffler and David, 1975). Susceptibility to viral onco­
genesis was also clearly influenced by an H-2 associated gene, 
called Rgv-1 (resistance to gross virus-1; Lilly, 1966;
Tennent and Snell, 1968).
Specific immune response (Ir) genes, which map within 
the MHC, are now recognized to exert positive (helper) and 
negative (suppressor) influence on immune responses. Separate 
subclasses of thymus-derived (T) lymphocytes mediate this 
helper or suppressor activity (Cantor, Shen and Boyse, 1976; 
Murphy, Herzenberg, Okumura, Herzenberg and McDevitt, 1976;
5
4Jandinsky, Cantor, Tadakuma, Peavy and Pierce, 1976) in the 
mouse and probably in all mammals.
Lilly (1972) and Lilly and Pincus (1973) have postulated 
that Rgv-1 may be an Ir gene that influences the level of 
immune response to virus-induced tumor associated antigens 
(TAA's). Data on levels of antibody produced by mice of 
different H-2 haplotypes to Gross and Priend tumor associated 
antigens support this hypothesis (Aoki, Boyse, and Old, 1966; 
Lilly, 1976).
CHICKEN
Mapping of the MHC in the chicken is less complete 
than in the mouse due to fewer available congenic strains 
which differ at the MHC. However, current data indicate that 
avian and mammalian MHC's have similar origins and functions.
The avian B (blood group) antigens are clearly analogous 
to the mammalian major histocompatibility antigens (MHA's) in 
their apparent molecular weight (about 40,000) and association 
with a smaller polypeptide (Bg-microglobulin) of molecular 
weight 11,500 (Ziegler and Pink, 1975; Ziegler and Pink, 1976). 
Furthermore, the amino-terminal regions of mammalian and avian 
MHA's contain homologous amino acid sequences (Huser, Ziegler, 
Knecht and Pink, 1978).
Biological properties attributed to both mouse and 
chicken MHC include: specification for antigens involved in
graft rejection, graft versus host reactions,and leukocyte 
identification; response level in MLR's; serological responsive­
ness to defined antigens; total serum complement levels; and
5susceptibility to oncogenic viruses (Shreffler and David,
1975; Hala, Vilhelm'ova and Hartmano.v.a, 1977; Morrow and 
Abplanalp, 1977).
INFLUENCE OF THE MHC ON TUMOR REGRESSION
MOUSE
Two mechanisms have been suggested by which an H-2 
linked gene might influence tumor progression or regression. 
First, an Ir gene, possibly identical to Rgv-1, might determine 
the level of response to tumor cells. In support of this,
Sato, Boyse, Aoki, Iritani and Old (1975) have shown that 
transplanted leukemia cells grow unimpeded in Balb/c 
(susceptible) recipients, but are strongly rejected by F^ 
hybrids of Balb/c and C57BL (resistant) mice. Only rejector 
mice produced cytotoxic antibodies specific to the leukemia 
cells.
A second hypothesis proposed by Freedman and Lilly
(1975) involves the H-2 gene Rfv-1, which confers resistance 
to Friend virus-induced leukemogenesis. Tumors were induced 
in vivo in mice of 3 different H-2 haplotypes (Freedman, Lilly 
and Steeves, 1975). Tumor cells were then explanted in vitro 
and assayed for virus production, virus-envelope antigen (VEA), 
and the ability to induce cytotoxic antibodies in competent 
hosts. Two lines of cells continued to produce virus and VEA, 
and to stimulate production of both virus-neutralizing and 
cytotoxic antibody throughout 150 passages. A third line 
remained VEA positive but became non-producing after 20 passages 
and was associated with production of virus-neutralizing but
6not cytotoxic antibody. Therefore, Rfv-1 may determine 
whether or not tumor cells continue to express the virus- 
associated antigen(s) against which the immune response is 
directed. Other viral antigen(s) (e.g. YEA) may be unaffected 
by Rfv-1.
CHICKEN'
In the chicken, B genotype is the most influential
determinant of tumor outcome. Collins et al. (1977) studied
1?2 segregants of a cross between EPRL lines 6-^ and 15]_- ®ie
percentage of chicks which died of terminal tumors, by haplo-
type, was: B^B^, 93%; B^B^, 26%; B^B^, 5%- Schierman,
Watanabe and McBride (1977)? in. an independent study, defined
the dominant R-Rs-1 gene, which determined the regressor
2
phenotype, and was associated with the B genotype. The 
recessive allele for progressive tumor growth was designated 
r-Rs-1, and was associated with the B-^ haplotype. It is 
unknown at present whether identical B designations in the 
two studies denote the same genes.
IMMUNITY TO RSV-IKDUCED TUMORS
Immunity to RSY-induced tumors was assayed in pure 
progressor or regressor line chickens by administering a 
challenge to the right wing at specific intervals after the 
first inoculation in the left wing (Gyles, Blythe, Test,
Bowanko and Brown, 1977)* B haplotypes of the two lines were 
not reported. While immunity developed earlier in the regressor 
line, by 15 days Post Inoculation (PI), chickens of both lines
7resisted a second challenge of either virus or tumor homogenate. 
McBride, Watanabe, and Schierman (1977) extended these findings 
to their chicken line (GB-l) which carries the r-Rs-1 (tumor 
progression) gene. In this case, all GB-l chickens tested were 
resistant to a second virus-challenge 8 days following primary 
tumor induction. An unexpected finding was that the second 
inoculation of RSV resulted in a marked increase in growth 
rate of the primary tumor. This enhanced rate of growth 
required an intact Bursa of Fabricius, even though bursectomy 
did not influence immunity to the secondary challenge.
T-CELL FUNCTION AMD MITOGEN REACTIVITY
The plant lectins phytohemagglutinin (PHA) and 
concanavalin A (con A) are specifically mitogenic for T 
lymphocytes. When cultured in vitro with optimum proportions 
of either con A or PHA, murine T-cells, but not B cells, were 
stimulated to synthesize SNA and DNA, and then to undergo 
mitosis (Janossy and Greaves, 1972). Most procedures in 
current use are derived from the microtest system of Park and 
Good (1972), which compared the incorporation of radiolabeled 
precursors of DNA into cells cultured with and without mitogen.
Specificity of PHA and con A for chicken T-cells was 
demonstrated by Greaves, Roitt and Rose (1968) and Toivanen 
and Toivanen (1973), respectively. Genetic control of stimula­
tion by con A was examined by Miggiano., North, Buder and Pink 
(1976), who showed a five-fold difference in response by 
lymphocytes from different inbred lines of chickens. The
8genetic locus responsible for this difference (designated Mrl) 
was not linked to the MHC.
MITOGEN STIMULATION AS A MEASURE OF 
- IMMUNE REACTIVITY IN CANCEROUS HOSTS
Mitogen stimulation of human peripheral lymphocytes 
was recommended as a means of testing over-all T-cell function 
(Fudenberg, Good, Hitzig, Kunkel, Roitt, Rosen, Rowe, Seligmann 
and Scothill, 1971)* Responses to PHA or con A, when included 
in immunoprofile studies of cancer patients, have given 
equivocal results, possibly due to the genetic heterogeneity 
of the human population (Cochran, Mackie, Grant, Ross, Connell, 
Sandilands, Whaley, Hoyle and Jackson, 1976; Concannon, Dalbow, 
Eng and Conway, 1977)* In one study (Dalbow, Concannon, Eng, 
Weil, Conway and Nambisan, 1977), statistically significant 
correlations were observed between the responses of lymphocytes, 
the stage of disease and the period of survival. However, the 
correlated responses were of limited prognostic value for 
individual patients. Interestingly, the response of lympho­
cytes of cancer patients to PHA was improved by washing the 
cells (Mannick, Constantine, Pardridge, Saporoschetz and 
Badger, 1977)*
Marek's disease of chickens has been associated with 
a depression of both thymus- and bursa- dependent immune 
systems (Burg, Eeldbush, Morris and Maag, 1971)* Animals 
with Marek's tumors had lower levels of stimulation for both 
con A (Lu and Lapen, 1974) and PHA (Theis, McBride and 
Schierman, 1975)? than did control birds. Schat, Schultz and
9Calnek (1977) found a transient depression of response to 
con A at 7 days post inoculation (PI) with, both oncogenic 
(GA-5) and non-oncogenic (SB-1) variants of virus. A permanent 
depression, which started 2 weeks PI, developed only in 
genetically susceptible chickens inoculated with GA-5.
CELLULAR STAINING WITH ACRIDINE ORANGE
Acridine orange (AO) is a metachromatic dye which 
exists in monomeric form at low concentrations in solution, 
and fluoresces green when excited with ultraviolet or blue 
light. At higher concentrations, AO dimerizes and fluoresces 
red (Bradley and Wolf, 1959)- Under appropriate conditions,
AO preferentially stains nucleic acids among other cellular 
polyanions (Darzynkiewicz, Iraganos, Sharpless and Melamed, 
1976). The dye intercalates into the DBA double helix as a 
monomer which fluoresces green (Lerman, 1963), while stacking 
via electrostatic interaction on phosphates of single-stranded 
nucleic acid, resulting in dye interactions and red fluorescence 
(Bradley and Wolf, 1959)* Differentiation of DBA and RNA by 
AO staining requires prior denaturation of double stranded 
RNA (Darzynkiewicz et al., 1976) which can be accomplished by 
the addition of EDTA (Braunstein, Melamed, Darzynkiewicz, 
Iraganos, Sharpless and Good, 1975)*
ACRIDIUE ORANGE ARP AUTOMATED OYTOPHOTOMETRY
A flow cytophotometer is an instrument which measures 
light emitted from individual cells passing through a flow
10
chamber, usually at a rate of 200 to 1000 cells per second.
In the application of AO to automated cytophotometry, cells 
flow past a 488 nm argon ion laser (Fig. 1) and emit red and 
green fluorescence which is measured by separate photomulti­
plier tubes. A multichannel distribution analyzer is then 
used to plot a point representing each cell on a histogram 
displaying the intensity of red and green fluorescence. 
Therefore, tens of thousands of cells can be individually 
analyzed for content of DNA and ENA in a short time.
AO staining plus automated cytophotometry has been 
used for automated differential counting of human leukocytes 
(Adams and Kamentsky, 1974)> for detection of changes in 
granulocytes with infection (Melamed, Adams, Traganos and 
Kamentsky, 1974) and for quantitation of PHA transformed 
lymphocytes (Braunstein et al., 1975)- Darzynkiewicz et al.
(1976) used a Cytofluorograf^ to follow the progression of 
PHA-stimulated human lymphocytes through the stages of the 
cell cycle. In pure lymphocyte preparations, they were able 
to differentiate 5 categories of cells: dead, GQ, G-^ , S and
Gg+M. Using nucleases, they also determined that at least 
88% of green fluorescence was due to DNA and at least 87% of 
red fluorescence was due to ENA.
ACKIDINE OKANGE STAINING IN CANCER DIAGNOSIS
AO staining for cytodiagnosis of cancer was first 
applied to exfoliative gynaecology and malignancies of the 
respiratory system (von Bertalanffy and Beckis, 1956). 
Currently, an automated prescreening program.is in use, which
11
Eig. 1. Diagrammatic representation of a flow cytophotometer.
Cells stained with acridine orange are excited by a 
4-88-nm argon ion laser, and red and green fluorescence 
is quantitated by separate photomultiplier tubes.
Each cell is represented on the oscilloscope as a 
point, with intensity of green fluorescence on the 
ordinate, and of red fluorescence on the abscissa.
12
Sample








Amplitude of red fluorescence
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indicates diagnosis "by AO staining is applicable to the entire 
spectrum of cellular abnormality occurring in the human female 
genital tract (Wheeless, Hardy and Balasubramanian, 1975)* 
Oucchiara (1976) correlated red fluorescence of AO 
stained peripheral lymphocytes with RSV-induced tumor develop­
ment in chickens. He observed by microscopic examination that 
red-staining peripheral cells increased from 0.3% before 
inoculation to about 24% when tumors were maximal. Neither 
lymphocytes from uninoculated controls nor from chickens 
inoculated with three non-oncogenic ENA viruses exhibited 
red fluorescence.
RATIONALE FOR THE PRESENT STUDY
While many parameters are known to correlate with 
tumor progression or regression, clearly defined cause and 
effect relationships remain elusive. Since a finite group 
of linked genes (MHO) on a single chromosome can determine 
survival or death of the tumor-bearing host, identifiable 
phenotypic differences should exist. The present study was 
undertaken to explore previously reported lymphocyte-asso­
ciated characteristics, in a system where the progression or 
regression of tumors was predetermined by MHO genotype. It 
is hoped that the results reported herein will add in part 
to the understanding of a very complex disease.
CHAPTER III
MATERIALS AND METHODS 
CHICKEN STOCKS
The single-comb white leghorn chickens used in this
study were developed at the Regional Poultry Research Laboratory
(RPRL), East Lansing, Michigan (Waters, 194-0). Line 6
2subline 3 (6 )^, homozygous B animals were obtained as day- 
old chicks from RPRL. The University of Hew Hampshire (UNH) 
poultry farm supplied fertile eggs from RPRL lines 6-^ and 6  ^
(homozygous Bg), RPRL line 15-j_ (homozygous B^), and Eg an<^- ^3 
progeny selected for B genotype. All chickens obtained from 
the UNH poultry farm were typed at the B-blood group locus by 
Dr. W. E. Briles, Northern Illinois University, DeKalb, 111.
BROODING AND HATCHING
Hatching-eggs from the UNH poultry farm were fumigated 
for 1 h in formaldehyde vapors, cleaned with 95% ethanol, and 
incubated at 37 0 until hatching. All chicks were brooded for 
3 to 6 weeks in conventional, electrically heated, thermostatic­
ally controlled brooding batteries in an isolated animal 
facility. Wherever possible, aseptic procedures were employed 
to keep chicks free from endemic diseases. Throughout the 
study, animals were fed medicated Merrimack Chick Starter 
(Merrimack Earmers Exchange, Concord, NH 03301) ad libitum.
1 4
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VIRUS STOCK AND INOCULATION
Bryan high-titer strain Rous sarcoma virus (RSV) in 
combination with the helper virus, Rous associated virus 
(RA.V-1), was obtained from Ur. L. B. Crittendon (RPRL), and 
stored in liquid nitrogen. The stock virus (designated RSV-1 
for a review of nomenclature, see Hanafusa, 1977) was diluted 
in Hanks balanced salts solution (see appendix) containing 5% 
fetal calf serum plus 100 units penicillin, 100 ug strepto­
mycin (GIBCO) and 10 ug hyaluronidase (Sigma Chemical) periml 
Six-week old birds were injected subcutaneously in the left 
wing-web with 0.1 ml of a 10-  ^dilution (approximately 20 
pox-forming units) of RSV-1 unless otherwise indicated.
Tumors appeared in 7 to 10 days and tumor size was scored 
subjectively according to Collins et al. (1977)*
BLOOU COLLECTION M B LEUKOCYTE SEPARATION
Blood samples were obtained by either cardiac or 
brachial vein puncture. Blood was collected aseptically into 
sterile heparinized (50 units/ml whole blood) syringes or 
vials and used in the following procedures to isolate lympho­
cytes:
a) Slow centrifugation (adapted from Jones, 1977)* 
Ten ml of blood were centrifuged in a 12 ml 
conical centrifuge tube for 10 min, 90 x g, at 
room temperature, in a swinging bucket centrifuge 
(International Model UV centrifuge with Model 240 
rotor). The buffy coat was carefully stirred
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into the plasma layer, and the lymphocyte rich 
plasma was removed with a sterile pasteur pipette 
and placed in a 14x10 mm centrifuge tube.
b) ZLcoll-Diatrizoate (ZD) centrifugation ( a 
modification .of the procedure of Archambault 
et al., 1976).
Two ml of blood were carefully layered over 2 ml 
of ZD in a 14x100 mm serological tube. ZD 
consisted of 9 percent ZLcoll (Sigma) and 33.9 
percent sodium diatrizoate (Winthrop) with a 
specific gravity of 1.085 to 1.090 (see appendix). 
Blood layered over ZD was centrifuged at 800 x g 
for 6 to 8 min in a swinging bucket centrifuge.
The lymphocyte-rich layer at the interface between 
ZD and plasma was removed with plasma (but no ZD) 
and placed in a 14x100 mm centrifuge tube.
DIFZEKEZTIAL AMB VIABILITY COUNTS
Differential counts of separated leukocytes were made 
by counting a minimum of 100 cells according to Zatt and 
Herrick (1954-). Briefly, cells were diluted (1:10 or 1:100) 
in Zatt-Herrick stain (appendix), left at room temperature 
for 2 min, then loaded into a hemacytometer (American Optical) 
and counted under 400X magnification.
Viable counts were made according to Hudson and Hay 
(1976). Cells were diluted in 1.11X (according to Gilmour, 
1976) Dulbecco's phosphate buffered saline (PBS) containing 
0.2% nigrosin (MG/B), left at room temperature for 5 min, and
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counted under 400X magnification in a hemacytometer. Refractile 
cells were counted as viable while dark cells (containing stain) 
were considered dead.
ACRIDIHE ORANGE (AO) STAINING
Peripheral blood leukocytes were separated by centri­
fugation on PD (procedure above), pelleted at 400 x g for 10 
min and resuspended in Dulbecco's l.llx PBS. Initially, cells 
were fixed and stained according to Cucchiara (1976); however, 
this procedure was unsatisfactory due to extensive lysis and 
aggregation of cells, rapid fading of red fluorescence, and 
loss of greater than 90% of cells during fixation. Consequently, 
the method of Darzynkiewicz et al. (1976) was used. Cells 
(optimally 2 to 5 X 10^), in 0.2 ml of serum or PBS, were 
added to 0.5 ml of a solution containing 0.1% Triton X-100 
(Packard), 0.2 M sucrose, 0.0001 M EDTA, and 0.02 M citrate- 
phosphate buffer (pH 5-0)- After 1 min, 1 ml of staining 
solution (0.002% AO, 0.1 M NaCl, 0.01 M citrate-phosphate 
buffer, pH 3-8) was added. Staining was for 5 min. A wet 
mount was prepared and cells were observed with a Reichert 
fluorescence microscope (exciting filter #KG-2/BG-12, barrier 
filter #1.5/0G l-l/BG-9).
Automated cytophotometric analysis (described earlier) 
required cells to be fixed and stained at UNH, and shipped to 
Los Alamos, Hew Mexico, for analysis. This required that the 
AO-staining characteristics be stable at 5-10 C for up to 48 
h. The glutaraldehyde post-fixation method of Cambier,
Wheeless and Patten (1977) caused extensive clumping of cells,
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possibly leading to red-staining artifacts (Darzynkiewicz 
et al. 1975)* Several variations of Cambier et_ al.'s procedure 
were tried, and the following method was developed.
Leukocytes were separated on ED, harvested with 
autologus serum, and diluted with 1.11X Dulbecco's PBS to a 
cell density of 2 .5  X 10^/ml. Two-tenths ml of cell suspension 
was added to 0.5 ml of cold phosphate buffered (0.1 M, pH 6.0, 
see appendix) 3*8% glutaraldehyde. Eixed cells were shaken 
for 15 sec and 1 ml of freshly prepared AO stain (30 ug AO/ml 
in 0.1 M citrate, 0.2 M phosphate buffer, pH 6.0) was added. 
Cells were stained 15 min at room temperature in the dark, 
centrifuged at 150 X g for 10 min, resuspended in 5 ml phosphate 
buffered glutaraldehyde, and stored at 5 C in the dark until 
analyzed.
CYTOPHOTOMETRIC ANALYSIS
Initially, ED-separated leukocytes were fixed in 70% 
methanol-30% acetone, and shipped to Dr. Z. Darzynkiewicz 
(Memorial-Sloan Kettering Cancer Center, New York City) for 
AO staining and analysis in a Systems 40 Cytofluorograf (Ortho 
Instruments). Later, glutaraldehyde fixed, AO stained cells 
were shipped to Dr. J. Leary (Los Alamos Scientific Laboratory, 
New Mexico) for analysis in the Los Alamos Cell Sorter as 
described. Cells were shipped and stored at 5 C in the dark 
up to 72 h before analysis.
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MITOGEN- ASSAYS
2 2 S SChickens with regressor (B B ) and progressor (B-Hr)
haplotypes were tested for the response of their lymphocytes 
to the T-cell mitogens concanavalin-A (con A) and phytohemag­
glutinin (PHA). Lymphocytes were isolated by slow centrifugation, 
washed twice with Dulbecco's l.llx PBS and resuspended in EPMI 
1640 culture medium (GIBCO) containing 2 mM L-glutamine 
(freshly added), 10% fetal calf serum (PCS), 100 ug streptomycin 
and 100 units penicillin (pen-strep) per ml (this media is 
designated 1640+). Cell density was adjusted to 1.33 X 10  ^
cells/ml and 150 ul were added to each of nine microtiter 
wells (Vanguard, U-bottom plate #1482) for each lymphocyte 
sample tested. Either 10 ug con A (Miles) or 80 ug PHA 
(Sigma) were added to each of 3 test wells in 50 ul of 1640+.
Fifty microliters of 1640+ were added to 3 control wells.
Cultures were incubated for 72 h in a humidified 5% C0£ 
incubator at 37 0, cultured for 16 h with 1 uCi tritiated 
thymidine (Hew England Nuclear, 5*7 Ci/m mole) and harvested 
by suction onto glass fiber filters (Whatman #934) using a 
Mash II (Microbiological Associates) cell harvester. Filters 
were dried at 80 C for 1 h, placed in scintillation vials with 
10 ml toluene (Baker) containing 0.4% 2,5 diphenyloxazole (PPO) 
and 0.00525% 1,4-bis /2’-(5-phenoxazolyl)7-benzene (POPOP)
(Packard) and counted in a Packard Tri-Carb scintillation 
counter (gain 51%» windows 50-1000). A stimulatory index (SI) 
was determined for each sample by dividing the mean cpm of 
mitogen treated cells by the mean cpm of -untreated cells.
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PROTEIN ELECTROPHORESIS
Serum proteins were analyzed by electrophoresis in 
discontinuous polyacrylamide gels containing sodium dodecyl 
sulfate (SDS). A model SE 500 slab gel apparatus with model 
PS101 power source (Hoefer) was used. Formulae (modified from 
Laemmli, 1970) were as follows:
1) A 12 cm long, 0.7 mm thick separating gel con­
sisted of 7-0% acrylamide (Ames), 0.025% N,N,N',N'- 
Tetramethyl-ethylenadiamine (Temed;Kodak), 0.1%
SDS (Matheson), and 0.025% ammonium persulfate 
(Kodak) in 0.375M Tris (hydroxymethyl) aminomethane 
(Tris-HCl; Sigma) buffer at pH 8.8.
2) A 1 cm long stacking gel was 5*0% acrylamide,
0.045% Temed, 0.1% SDS, and 0.045% ammonium 
persulfate in 0.125M Tris-HCl at pH 6.8.
5) Samples contained from 5 to 100 ug protein in 
0.0625 M Tris-HCl (pH 6.8) containing 2.0% SDS, 
10.0% glycerol (Fisher) 5-0% 2-mercaptoethanol 
(Sigma) and 0.01% bromphenol blue (Allied).
4) Electrode buffer was 0.025 M Tris, 0.192 M
glycine (Sigma) and 0.1% SDS. Ten or 20 ul of 
sample were added to each well of the slab, and 
electrophoresed at 12 mA for 45 min, then at 
"20 mA until the tracking dye migrated 12 cm 
(approximately 5 h).




EEEECT OE HOST GENOTYPE AND AGE ON TIMOR DEVELOPMENT
Originally, line 6^ chickens were used to compare
leukocytes (by acridine orange staining) and serum (by gel
electrophoresis) from tumor-bearing and non tumor-bearing
chickens. Table 1 shows that maximum tumor was obtained in
only 4 of 105 chickens from this line; three cases occurring
during an epidemic of aplastic anemia in the flock, and thus
of questionable value. Aseptic procedures, isolation, and
use of specific pathogen-free (SPP) birds from RPRL resulted
in even fewer tumors of maximum size (Table 1, RG18HLthrough
H4). Consequently, P£ and progeny of crosses between lines
15^ and 6^ or 6-^ were used. Table 2 shows that the present
results concurred with those of Collins et al. (1977); birds
2 2with the genotype B B usually developed tumors which regressed, 
5 5while B-fEr birds invariably died with a large tumor. Moreover,
2
there was no apparent difference between the B allele of lines
6-^ and 6^ as it affected tumor regression. Nor did the
source of chicks (RPRL or UNH) affect TPI's.
The TPI of B^B^ birds (6-^  x 15q? J’j) was consistent
when inoculated between 6 and 8.5 weeks of age (Table 5)- 
2 2B B chickens, when challenged at the older age, may have 
regressed their tumors more quickly.
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Table 1. Distribution of Line 6  ^Chickens According to Tumor Profile Index (TPI),
and Attainment of Maximum Tumor Size, by Hatches.
Age au 
Inoculation TPI1 2Maximum
Hatch (Weeks) 1 2 3 4 1 Tumor Total
RMZ H4
UNH Line 6-z 3 6 3 3 6 0 65 l5 18
RMZ H5
UNH Line 6- 
3 6 0 5 9 0
45 25 18
RG18 Hi 
RPRL Line 6^ . 6 0 2 5 0 1 1 • 8
RG18 H2 
RPRL Line 6^ 7 4 14 14 0 0 0 32
RG18 Hz
RPRL Line 6* 3 6 1 5 4 0 0 0 10
RG18 %
RPRL Line 6^ 6 7 9 3 0 0 0 19
TOTAL 15 38 41 0 11 4 105
Tumor profile indexes (TPI's) according to Collins al. (1977), TPI 1-3 = Regression 
before 70 days; TPI 4 = tumor palpable at 70 days; TPI 5 = death due to tumor prior to 
70 days.
2
Number of birds with a maximum tumor score size of 6, according to Collins et al., 1977.
3
TPI's and maximum tumor size may be elevated due to epidemic of aplastic anemia during 
these experiments.
Table 2. Distribution of Pp Generation Progeny According 
to Genotype and TPI, Combined Data from Three 
Hatches per Mating.
_____________PARENTAL LIMES____________












1 12 0 0
0 19 3 0
2 4 2 0
0 0 2 0
24 _1 _i 18
27 36 8 18
■*\Bbr TPI Designations, See Table 1.
Table 3. Distribution of 6j_ x 15i (F3) Chickens According to Tumor Profile Index (TPI),
Attainment of Maximum Tumor Size, and Age at Virus Inoculation, by Hatches.
Age
Inoculation TPI1
Hatch (Weeks) B-Genotype 1 2 3 4 5
----
Tumor^
RG21HC-W 6 55 0 0 0 0 9 9IP 22 1 6 4 0 0 0
RG21H[- 6 55 0 0 0 1 11 11IP 22 7 2 4 2 0 0
RG21H4W 7 55 0 0 0 0 7 5
22 0 6 0 0 0 O'
RG21H-JW 7.5 55 0 0 0 0 5 5
22 1 6 3 0 0 0
RG2IH7W 8 . 55 0 0 0 0 5 50 22 4 1 1 0 1 1
RG21H1QW 8.5 55 0 0 0 0 10 9














For TPI Designations, See Table 1.
2
Humber of birds with a maximum tumor score of 61 according to Collins et al., 1977.
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LYMPHOCYTE PURIFICATION FROM BLOOD SAMPLES;
A COMPARISON OE METHODS
Lymphocytes were isolated according to Archambault 
et al. (1976), Lee (1974-), Jones (1977), and Miggiano et al. 
(1976). A modification of the procedure of Archambault et al. 
(centrifugation through ED) resulted in greater than 90% 
recovery of lymphocytes from blood, but thrombocyte contamina­
tion often equalled lymphocyte recovery. Conversely, the 
procedure of Jones (slow centrifugation) recovered about 10% 
of blood lymphocytes, with few contaminating cells. The other 
methods were unsatisfactory.
Table 9- shows recovery and purity for 6 blood samples 
which were split, and the leukocytes separated by both ED and 
slow centrifugation. Note that ED recovered 7*7 times as many 
cells as slow centrifugation, but only 60% of these cells were 
lymphocytes. Leukocyte purification was unsuccessful in about 
15% of chickens with large tumors (e.g. sample #NB in Table l). 
Leukocytes were purified from a total of 47 samples by slow 
centrifugation alone, with a mean recovery of 4.06 x 10^ cells/ 
ml of blood. Isolated leukocytes consisted of greater than 90% 
lymphocytes, 0.5-9% erythrocytes, and less than 1% thrombocytes 
or granulocytes.
Seventy-one samples purified by ED centrifugation had 
a mean recovery of 2.92 x 10^ cells/ml, with 23.2-88.5% lympho­
cytes, 0.5 to 30.7% erythrocytes, 3.4- to 79-4% thrombocytes, 
and 0.5 to 26.2% other leukocytes. The respective means were











Sample # S PD S PD S PD S PD S
7003 1.7xl06 1.7xl06 63 93.4 10.4 0.6 16.8 5.4 9-8 0.6
7108 4.0xl06 4.3x105 62.7 91.5 1.3 3.2 33.6 3.9 2.5 1.4
7187 2.7x10? 6.5x10 6 60.1 88.2 1.3 4.4 33.3 4.4 5.3 3.0
7196 4.1x10? 1.4xl06 50.8 88.9 2.3 2.7 44.4 8.1 2.5 0.3
7201 3.0x10? 2.2xl06 61.0 94.9 10.2 0 20.3 2.9 8.5 2.21—1 £ 1.2xl08 2.9xl06 15.0 32.1 63.3 57.4 10.6 ZiO 11.1 3-3
Mean 2.1x10? 3.2xlOS 59.5 91.4 5.1 2.2 29-7 4.9 5-7 1.5
Standard
Deviation 1.7x10? 2.2xlOS 5.02 2.86 4.77 1.84 11.17 1.98 3.36 1.12




53-2%, 7*7%? 33% and 6.6%. Cells were consistently greater 
than 90% viable for both methods of separation.
ANALYSIS 0? LYMPHOCYTES BY 
ACRIDINE ORANGE STAINING
A COMPARISON OR MICROSCOPIC METHODS
Lymphocytes were originally stained and the percentage 
of ED-separated leukocytes having intense red fluorescence was 
determined according to the method of Cucchiara (1976). One 
hundred seven samples from uninoculated controls, 18 from 
animals with maximum wing tumors, and 9 from chickens with 
smaller wing tumors were analyzed. Mean percentages of 
intensely red fluorescing cells, -  standard deviations were 
6.25 -  7.67, 29.05 - 22.56 and 14.1 i 25.52, respectively.
Thus great variability among samples and poor correlation of 
the incidence of red fluorescing cells with tumor size was 
observed, contrary to the results of Cucchiara (1976). Examina­
tion of additional samples showed that this procedure eliminated 
greater than 90% of cells from analysis, caused extensive 
lysis, and was accompanied by rapid fading of red fluorescence. 
Moreover, contaminating polymorphonuclear cells, if any, could 
not be differentiated from mononuclear cells.
Due to the unacceptable variability of the above 
procedure, the method of Darzynkiewicz et al_. (1976) was used 
for all remaining fluorescence microscopy. Since cells were 
stained without fixation and in suspension by this method, no 
cell loss or fixation artifacts were encountered. Nuclear 
integrity was maintained, and cell types could be distinguished
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microscopically (Fig. 2). However, fading of red fluorescence 
still occurred within 15 to 30 min.
TIMOR ASSOCIATED INCREASE IN BED FLUORESCING LEUKOCYTES 
DETECTED BY AO STAINING ACCORDING TO DARZYNXIEW1CZ.
Tumor-hearing chickens had significantly (P< .05) more 
red fluorescing cells than controls between days 21 and 29 
post inoculation (Fig. 3). Nine observations on positive 
controls (chickens with maximum wing tumors) had a mean of 
22.77% intensely red cells and a standard deviation of 8.17.
Thus the staining method of Darzynkiewicz confirmed the 
increased red fluorescence of lymphocytes from tumor-bearing 
hosts which had been observed by Cucchiara (1976). However, 
these results differed from the former study in that increased 
red fluorescence accompanied tumor growth, rather than preceding 
it, and great variation existed among control samples.
Although this staining procedure was an improvement, 
the subjectivity of manual counting still resulted in unaccept­
able variation. For example, counts of red-fluorescing cells 
in a single sample by two technicians differed as much as six­
fold. Also, about 5% of samples had inexplicably high or low 
counts, and in a second study dealing with the appearance of 
red fluorescing peripheral lymphocytes (RGlSHg), there was no 
significant difference between red-cell counts of tumorous 
and control animals.
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Fig. 2a. Photomicrographs of FD-separated cells after staining with 
acridine orange according to Cucchiara (1976). (X2800)
Fig. 2b. Photomicrographs of FD-separated cells after staining with
acridine orange according to Darzynkiewicz et al_.(1976) (X2800)
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Fig. 3. Mean percentage of red fluorescing cells after stain­
ing with, acridine orange according to Darzynkiewicz 

















TIMOR-RELATED INCREASE IN LEUKOCYTES WITH ELEVATED RED 
FLUORESCENCE AS CONFIRMED BY AUTOMATED CYTQPHOTOMETRY.
To alleviate the problems of manual counting, ten samples
ng \
were analyzed in a cytofluorograph7— ' automated cell cyto- 
photometer by Dr. Z. Darzynkiewicz. Cells were isolated from 
cardiac blood by centrifugation on FD, added in autologous 
plasma to 3 ml of l.llx PBS containing 2mM MgClg, and centri­
fuged at 400xg for 10 min. Pellets were resuspended in 2 ml 
of l.llx PBS, and split into 2 aliquots, one of which was 
added to 9 ml of 50% acetone, 50% ethanol. Aliquants of these 
fixed cells were shipped in 1-dram vials (Wheaton) at 10 C 
for analysis. At the laboratory of Dr. Darzynkiewicz, the 
samples were centrifuged, resuspended in 0.15N NaCl containing 
0.05 N HC1, and stained with citrate (0.1M) - phosphate (0.2M) 
buffered (pH 6.0) saline (0.15 M NaCl) containing 6 ug/ml 
acridine orange. Ten thousand cells per sample were individu­
ally assayed for intensity of green or red fluorescence, and 
a frequency distribution was generated with a multi-channel 
analyzer. Fig. 4 shows typical distributions for red fluores­
cence of cells from three control chickens and three animals 
with maximal tumors. Few cells from controls, but many from 
tumor-bearing chickens had an intensity of red fluorescence 
greater than 40, based upon a relative scale from 0 to 100.
To determine whether or not cells with elevated red fluorescence 
could attach to a substrate, 1x10^ cells from each of 6 
samples were suspended in 20 ml of BME culture medium (GIBCO)
+ 10% FCS in a culture dish (Falcon #3007) and incubated in a 
5% CO2 incubator at 37 0 for 30 min. Non-adherent cells were
34-
Fig. 4. Frequency distributions for red fluorescing leukocytes 
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transferred to a second dish, and incubation continued for an 
additional 30 min. After monolayering, cells remaining in 
suspension were washed, fixed, and shipped to Dr. Darzynkiewicz' 
laboratory for analysis, as described above.
Table a summary of cytophotometric analysis, shows 
elevated red fluorescence in animals with large, progressing 
tumors when compared with regressors or controls. Host number 
10, which had a massive tumor when sampled, did not have cells 
with elevated red fluorescence, and its tumor completely 
regressed. Table 5 also shows that monolayering removed less 
than half of the cells with elevated red fluorescence for 
both controls and tumorous chickens. Since cells in the 
second dish of the monolayering procedure were not near con- 
fluency, it is presumed that remaining cells were unable to 
attach to substrate, and were probably lymphoid cells. The 
Pearson correlation coefficient for tumor progression (set 
to equal l) or regression/control (set to equal 2) versus 
automated counts of red fluorescence was .966; for manual 
counts versus progression or regression/control was .793; 
and for manual versus automated counts was .772. Therefore, 
automated counts were well correlated with tumor outcome, 
manual counts were not.
A second experiment done in collaboration with 
Darzynkiewicz examined only cells remaining in suspension 
after monolayering.
Table 6, with one exception, shows a positive correla­
tion between elevated red fluorescence and tumor progression, 
especially for animals with maximal tumors when samples were
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Table 5« Elevated Red Fluorescence of Acridine Orange
Stained Leukocytes in Tumor-Bearing Hosts, I.
Tumor Score Response Of % of Cells with. Elevated
At Time of Host To Red Fluorescence
Host Sampling Tumor (Not Monolayered) (Monolayered)
1 0 X — 2.8 1.3
2 0 — 2.3 1.3
3 0 — 7-3 NT2
4 0 — 3.6 NT
5 0 — 1.9 NT
6 4 Regression 1.1 NT
7 3 Regression 1.7 1.2
8 6 Died 16.1 11.8
9 6 Died 13.0 8.4




Table 6. Elevated Red Fluorescence of Acridine Orange
Stained Leukocytes in Tumor-Bearing Hosts, II.
Tumor Score
At Time Of Response of % Cells With. Elevated
Host Sampling Host to Tumor Red Fluorescence
11 O1 — 0.8
12 0 — 6.9
13 0 — 3.4
14 2 Died 8.6
15 2 Regression 2.3
16 6 Died 17-1
17 6 Died 10.2
18 6 Died 18.3
19 6 Regression 24.4
20 6 Died 44.4
10, Uninoculated Controls
taken. Host number 19, whose wing tumor regressed, died 
shortly after the experiment ended. Since no necropsy was 
performed, the presence or absence of visceral metastasis is 
unknown, and its elevated count remains an enigma.
It is, therefore,.evident that leukocytes from the 
peripheral blood of chickens with large RSV-induced tumors 
had elevated red fluorescence relative to controls. It is 
assumed that this increase in red fluorescence is due to 
an increase in lymphocyte ENA, and is a result of tumor- and/ 
or helper-virus pathogenesis. This point will be discussed 
more fully in later sections.
CORRELATION Of1 BED AND GREEN FLUORESCENCE WITH DIFFERENTIAL 
CELL-TYPE.
Additional automated cytophotometric analyses were 
done by Dr. J. Leary, Los Alamos Scientific Laboratory, Los 
Alamos, N.M. These samples, which were fixed in glutaraldehyde 
as described earlier, confirmed elevated red fluorescence in 
cells from animals with large progressive tumors. Further, 
comparison of differential counts with histograms generated 
by the cell cytophotometer allowed assignment of given cell 
types to particular peaks of red fluorescence. Histograms 
from samples with greater than 80% red blood cells are shown 
in Fig. 5, indicating that erythrocytes have the lowest red 
fluorescence of blood cells. Histograms in Fig. 6 represent 
samples with a low lymphocyte to thrombocyte ratio, and in 
Fig. 7 samples with a high lymphocyte to thrombocyte ratio. 
These figures indicate that ljmphocytes had more intense red
Big. 5- Histograms generated from automated analysis of red
and green fluorescence after acridine orange staining 
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Fig. 6. Histograms generated from automated analysis of red
and green fluorescence after acridine orange staining 
of cells. II. Sample A, 20% lymphocytes, 70% 
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Fig. 7- Histograms generated from automated analysis of red
and green fluorescence after acridine orange staining 
of cells. Sample A, 85% lymphocytes, 10% 
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fluorescence than erythrocytes, with thrombocytes intermediate 
between the two.
The above results suggest that neither erythrocytes 
nor thrombocytes could account for the elevated red fluores­
cence of cells from tumor-bearing hosts. Since samples were 
not significantly contaminated by cells other than these, 
cells with elevated fluorescence were apparently lymphocytes 
and/or monocytes. Such cells which remained after monolayering 
were evidently lymphocytes.
RELEASE OF NUCLEIC ACID FROM 
LEUKOCYTES BY WASHING
Cucchiara (1976) reported that washing lymphocytes 
with PBS released ERA from spleen cells of birds with large 
tumors, but not from cells of non-tumorous hosts. He corre­
lated this release with loss of red fluorescence and concluded 
that ERA was released from the exterior of the cytoplasmic 
membrane. A washing experiment was done according to Cucchiara 
(1976) in an attempt to isolate and characterize this ERA.
Table 7 indicates that material which absorbed light at both 
260 and 280 nm appeared in the supernatant fluid from cell 
washes, whether cells were from tumorous or non-tumorous hosts. 
To determine whether this material could have been liberated 
by cell death and/or lysis, another experiment was done in 
which cell numbers and viability were monitored. Table 8 
shows that greater than 36% of cells were lost, presumably 
through lysis, after 3 washings.
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Table 7. light Absorbance at 260 nm (A^gq ) or 280 nm C ^ q q) 
of Supernatant PBS after Washing of Leukocytes and 
Centrifugation at 400xg for 10 min.
Splenic lymphocytes Prom Splenic Lymphocytes Prom 
Wash #  2 Tumorous Hosts 1 Uninoculated Host
A260 A280 A260 A280
1 1.87 1.18 1.37 0.88
2 1.10 0.77 0.67 0.48
3 1.08 0.83 0.68 0.56
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Table 8. Cell Viability, Total Cell Number, and Light 
Absorbance at 260 nm (Ap^n) of Supernatant 
PBS After Washing of LeuRocytes and Centrifugation 














1 5.4x106 81.5 0.70 1.7xl07 86.9 2.85
2 4.2xl05 76.2 ND5 1.4xl07 83-2 ND
3 2.9xl05 69.0 0.09 l.lxlO7 84.1 0.12
■^ Total count and viability determined prior to centrifugation 
2
Apgo determined from cell supernate following centrifugation 
%D, Not Determined
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While the amount of 260 nm absorbing material was 
roughly proportional to the number of cells lysed, more 
material was liberated per cell lost in earlier than in later 
washes. A reproducible decrease in red fluorescence of AO 
stained, washed cells was not detected by microscopic observa­
tion. Automated cytophotometry was not used to examine washed 
lymphocytes.
ABSENCE OS’ DIFFERENT SERUM PROTEINS IN TUMOR-
BEARING AND NON TIMOR-BEARING HOSTS
Cucchiara (1976) reported that chickens with maximal 
tumors had a unique serum protein which was absent in unin­
oculated controls. In an attempt to isolate and characterize 
this protein, SDS-PAG electrophoresis of serum samples was 
done according to Cucchiara. Seventy-five samples from 
tumorous animals and 102 from controls were examined, usually 
in duplicate or triplicate. No consistent difference was 
observed in the serum proteins of tumor-bearing and control 
chickens.
EFFECT QE GENOTYPE ON THE DEVELOPMENT 
OF IMMUNITY
SIMILAR STIMULATION BY T-CELL MITOGENS OF LYMPHOCYTES FROM 
NORMAL B2B2 AND B^B^ CHICKENS.
The proliferation of thymus-derived (T) lymphocytes 
following stimulation with the T-cell specific mitogens con A 
and PHA was examined. Lymphocytes from 3 chickens per haplotype 
were tested separately in most experiments as described. While
i
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replicates of the same sample were very reproducible, a wide 
variation occurred among birds of the same genotype. There­
fore, while Table 9 shows some large differences in mean
2 2 5 5stimulatory index (SI) between B B and ByBy chickens, only 
in the con A assay of experiment 3 was the difference 
statistically significant (P <.05)•
SIMILAR NUMBERS OP PERIPHERAL LYMPHOCYTES IN NORMAL B2B2 AND 
B^B^ CHICKEN'S.
During preparation of lymphocytes for mitogen studies, 
the number of cells isolated per ml of blood was recorded.
Table 10 shows that in 4 experiments, the mean cell yield
2 2 5 5from B B birds was slightly higher than from B<B^ animals.
Only in experiment 2 was the difference statistically signi-
2 2ficant (P< .05). Therefore, prior to tumor induction, B B 
and B^B^ hosts appeared to have equal numbers and mitogenic 
reactivity of peripheral lymphocytes.
GENOTYPE ASSOCIATED RESISTANCE OR SENSITIVITY TO SECONDARY 
TUMOR-INDUCTION.
McBride et ad. (1977) reported that chickens with a 
progressing RSV-induced tumor in one wing were resistant to 
a subsequent challenge in the second wing between 8 and 18 
days after the first inoculation. However, in animals which 
resisted the second challenge, accelerated growth of the primary 
tumor was observed. The method of McBride et al. was used 
to determine whether or not anti-tumor immunity and/or tumor 
enhancement develop similarly in RPRL chickens. Six to 8-week
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Table 9- Mean Stimulatory Indexes (SI) of B B and B^B^
Lymphocytes After Culture With the T-Cell Mitogens 
Concanavalin A (Con A) and Phythomegagglutinin (PHA)
SI con A SI PHA
Experiment # B2B2 b5b 5 b2b2 b5b 5
1 7.02(3) 10.91(3) 2.64(3) 2.03(2)
2 21.05(4) 9.47(4) 6.64(4) 3-08(3)
3 18.5 (4)2 73.25(2)2 7-77(5) 9.5K2)
4 4.6 (3) 10.63(3) 3.14(3) 3.59(3)
^Numbers in () = #  samples assayed 
2
P < .05 hy one-way analysis of variance
Table 10. A Comparison of the Lymphocyte-Yield per ML 
Blood from B2B^ or B^b5 Chickens.












"4? < .05 "by one way analysis of variance
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2 2 5 5chickens of both genotypes (B B and B^B^) were inoculated
with about 20 PPU RSY-1, then challenged with the same dose
between days 9 and 12 following the first inoculation. B^B^
chickens were not immune, since they invariably developed a
2 2tumor in both wings; 94-. 7% of B B birds were resistant to
the second challenge (Table 11). Without exception, tumors
2 2which developed in B B animals underwent spontaneous regres­
sion. In four experiments, subjective tumor scores indicated 
no enhancement of primary tumor growth by a second virus
challenge. In fact, accelerated regression by the regressor 
? ?genotype (B B ) was observed (Pig. 8).
Two additional experiments were performed to more
objectively monitor tumor growth. Chickens were inoculated
in the left wing at 8 weeks of age, and about half were
challenged 12 days later in the right wing. A caliper was
used to record the length, width and thickness of the primary
tumor between 10 and 28 days following the first inoculation.
Tumor volume was determined according to the formula for an
ellipsoid (4-/3 ifabc) where a, b and c represent radii.
In these experiments, mean primary tumor volumes of
animals which received a single inoculation did not differ
significantly from those which were rechallenged (Pigs. 9 and
10). In both cases, tumors of B^B^ chickens increased
exponentially until death of the host at 23 to 30 days post-
2 2inoculation (PI). Tumors of B B chickens began to regress 
between 14- and 17 days PI. This indicated, in apparent 
contradiction of McBride at al. (1977) that secondary inoculation 
had no effect on growth of primary tumors. It should be
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Table 11. The Proportion of B B and B^B^ Chickens Which 
Developed Tumors in Left Wing Inoculated With 
ESV-l at Day 0 and Eight Wing Inoculated at 




Proportion of Birds That 
Developed Tumors in 
Left Wing Eight Wing
1 10 8/8 1/8
2 10 6/6 1/6
B2B2(l_) 3 10 5/5 0/5
4 12 9/9 0/9
5 12 10/10 0/10
TOTAL 38/38 2/38
l 10 4/4 4/4
2 10 4/4 4/4
b5B5(!) 3 10 5/5 5/5
4 12 7/7 7/7
5 12 5/5 5/5
TOTAL 25/25 25/25
(l_) In every case, the tumor(s) regressed completely
(]?) In every case, the tumor grew progressively and the animal 
died before 36 days post inoculation
55
Fig. 8. Mean primary tumor scores for chickens inoculated 
in one wing, or two wings at 10-12 day intervals; 
comt>ined data for four experiments. EB^, l wing, 
N = 24; , 2 wings, N = 25; a b5, 1 wing,






Fig. 9* Mean primary tumor volumes for chickens inoculated 
in one wing, or doth wings at 12 day intervals. I. 
□ , B^, 1 wing, N = 6; ■ , B^, 2 wings, N = 8;











Pig. 10. Mean primary tumor volumes for chickens inoculated 
in one wing, or "both wings at 12 day intervals. II. 
Q, B^ :, 1 wing, N = 6; ■, B^ r, 2 wings, N = 8;












noted, however, that genetic stocks of both virus and host 
were different in these two studies.
NEUTRALIZATION 01 VIRUS BY REGRESSOR SERUM
Pooled serum from 5 birds which had completely
regressed primary tumors was tested for neutralization of
RSV-1 according to Whitfill _et al. (1978). Blood was collected
from the brachial vein, clotted at 37C for 1 h, refrigerated
for 1 h, and the serum harvested and pooled. Pive-tenths ml
_2of serum was mixed with an equal volume of a 5x10 dilution
of RSV-1, and incubated at room temperature for 45 min.
Hyaluronidase in the virus diluent was twice the usual concen­
tration prior to mixing with serum. After incubation, 0.1 ml 
of virus-serum mixture was inoculated into the wing webs of 
each of 6 susceptible animals, none of which developed tumors. 
Virus treated identically with serum from "normal" chickens 
produced tumors in each of 8 birds inoculated. Therefore, 
serum from regressors neutralized RSV-1 while serum from 
uninoculated controls did not.
EFFECT OP GENOTYPE ON DEVELOPMENT OF HUMORAL ANTI-VIRAL 
IMMUNITY.
To determine whether or not humoral neutralization of 
virus in vivo could be responsible for the failure of secondary 
tumors to develop at 10-12 days PI, sera from 10 and B^B^
tumor-bearing birds were tested for serum neutralization.
Serum from one uninoculated animal per genotype was tested 
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tested, and from 70% of B^B^ birds failed to neutralize the
2 2virus. Although over two-thirds of B B ' s tested lacked
detectable anti-viral antibody, all were resistant to secondary
tumor-induction. It, therefore, seems unlikely that in vivo
neutralization of virus by antibody is responsible for the
2 2observed resistance of B B chickens at 12 days PI. This 
concurs with the work of McBride et aA. (1977)5 since neonatal 
bursectomy did not alter development of immunity to a second 
challenge.
Retarded development of humoral anti-viral immunity 
5 5occurred m  B<Er hosts, with virus-neutralizing activity 
present at 20 but not 12 days PI. B^'s were not tested for 
anti-tumor immunity in vivo after day 12 PI, since the latency 
period for tumor-development would then extend into the 
expected mortality-period (days 22-28 PI).
CHAPTER V
DISCUSSION
The foregoing experiments indicate critically different
time courses for the development of anti-tumor and anti-viral
2 2 5 5 2immunity m  B B and B<B-' chickens. In the B host, a rapid
response to "both tumor and viral antigens results in neutrali­
zation of virus and regression of tumors. On the other hand, 
a delayed or suppressed response in the ~Sr host results in 
rapid tumor growth and early mortality.
HOST GENOTIPE, AGE AND TUMOR DEVELOPMENT
A strong association exists in mouse (Shreffler and
David, 1975)» chicken (Collins et al., 1977) and perhaps human
(Dausset, 1977) "between major histocompatibility complex (MHC)
haplotype and resistance to cancer. The observations of
Collins et al. (1977) using Eg generation chickens, have been
2 2extended to F^ progeny by the present study. B B chickens 
usually developed tumors which regressed, while B^B^ animals 
developed progressive tumors which resulted in early death. 
Furthermore, neither age at inoculation (from 6 to 8.5 weeks) 
nor source of the B allele (strain 6^ or 6-^ ) had an effect 
on tumor outcome. Therefore, the gene(s) responsible for the 
observed phenotypes is probably identical in lines 6^ and 6^.
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LYMPHOCYTE PURIFICATION AND MITOGEN STUDIES
Lee (1974-) noted the importance of removing thrombo­
cytes from lymphocyte preparations which were to he assayed 
for stimulation hy mitogens. She was -unable to detect 
stimulation of cells purified by either albumin flotation or 
ficoll gradient. In an experiment preliminary to the present 
study (unpublished), lymphocytes were purified from a split 
blood sample by both ficoll-diatrizoate (PD) and slow centri­
fugation. Only lymphocytes from the latter method were 
stimulated by con A. Numerous differential counts and automated 
cytophotometric analyses confirmed, contrary to Archambault 
et al. (1976), extensive thrombocyte contamination of PD- 
separated leukocytes, which may be responsible for the failure 
of mitogen stimulation. Thrombocytes were also reported to 
interefere with the mixed leukocyte reaction (Jones, 1977)*
While stimulation of cells separated by slow centrifu­
gation was adequate, it should be noted that this method 
recovered less than 10% of blood lymphocytes. It is unknown 
whether or not recovery was random, or selective for lympho­
cytes of a given size, density or type. However, in agreement 
with what is found in peripheral blood, these cells were nearly
all small lymphocytes by morphological criteria and staining
2 2reactions. These experiments indicate that 6-week old B B 
5 5and B-'B^  chickens have normal numbers of functional peripheral 
T-cells.
LACK OF ANTI-TIMOR IMMUNITY IN B5B5 CHICKENS
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Either humoral and/or cell-mediated immunity may account 
for resistance to RSV-induced tumors.
Animals studied by both. McBride et al. (1977) and by 
Gyles et al. (1977)» from’ strains of chickens prone to progres­
sive tumors, all developed immunity to subsequent virus 
challenge. In the former study, all birds were immune by 8 
days post-inoculation (PI), even after effective neonatal 
bursectomy. In the latter investigation, 33% were immune at 
10 days PI, and 100% at 15 days PI. McBride et aY. (1977) 
observed a bursal dependent enhancement of primary tumor 
growth following secondary virus challenge.
Neither anti-tumor immunity nor enhancement of tumor 
growth were observed in BuEv chickens in the present investiga­
tion. Furthermore, RSV-neutralizing antibody was not detected 
5 5m  serum from B<Er chickens at 12 days PI. The absence of
5
early anti-tumor and anti-viral immunity in Bx animals may
be due to several factors, including the following:
l) The B^B^ haplotype may be associated with general
immuno-incompetence due to retarded development of the immune
system. This seems unlikely since the present study shows
the number of circulating lymphocytes and their response to
2 2 5 6mitogens to be similar in B B and B-'B-' chickens at six weeks 
of age. Also size and gross appearance of thymi and bursae 
from more than 50 birds of each blood type were similar when 
removed at three weeks of age for antigen preparations (unpub­
lished). Furthermore, B^ and B^ birds rejected allogeneic skin
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5grafts equally well; complement levels of Ir's were equal to
2
or greater than B 's at six weeks of age; and total serum IgG 
was normal for six-week old chickens of both lines 6-^  and 15  ^
(Heinzelmann; Miller; Collins and Savage, respectively, 
personal communications)..
2) BSV-determined, tumor-associated antigen(s) which
O p
is(are) responsible for prompt rejection by B B chickens may
be structurally similar to a antigen. This would account
2 2for both prompt rejection of tumors by B B animals and lack
5 5of reactivity by B^B^'s. That tumor cell transplants from
5 5 2 2B-'Br birds failed to grow in B B hosts, but grew progressively
in B^B^ birds (unpublished) is consistent with, but hardly
supportive of this hypothesis. Also, an experiment by
Heinzelmann (personal communication) indicated that little
2influence on tumor regression m  B birds resulted from prior
5
neonatal induction of tolerance to Bx erythrocytes. What the 
effect would be of tolerance to B^ leukocyte antigens is 
presently unknown.
e c p p
3) The immune system of BnB^, but not B B animals, 
may be seriously debilitated by ESV-1 tumorigenesis or infec­
tion. Decreased serum complement levels (Miller, personal 
communication) and failure to mount a rapid immune response 
against either virus or tumor, indicate a non-specific immune 
impairment and thus support this view. This immune impairment 
may be induced by the tumorigenic Eo.us sarcoma virus, by the 
leukosis-causing Eous associated virus (EAV-l) or by unknown 
factors. More experimentation is needed to either support
or refute this hypothesis.
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4-) A B^-linked gene(s) may be responsible for
specific suppression of anti-tumor immunity. This hypothesis
is most consistent with information from the mouse. That
either adoptive transfer of lymphocytes (Fugimoto, Greene and
Sehon, 1976) or passive transfer of a lymphocyte-derived
factor (Greene, Fujimoto and Sehon, 1977) from mice with growing
tumors, into previously tumor-immunized mice, will result in
enhancement of tumor growth, has been demonstrated. This led
to the identification of suppressor T-lymphocytes, and factors
produced by them, which specifically repress the immune
response to a particular antigen. Both suppressor cells
(Murphy et al., 1976) and factor (Greene, Pierres, Dorf and
Benacerraf, 1977) contained determinants coded for by the
I-J subregion of the H-2 (mouse MHC) complex.
Suppressor activity has been detected in chicken
thymocytes (Droege, 1975)) a;&d- this may be the reason for
5 5progressive tumors in B-\Er hosts. An early immune response 
(12 days PI) was lacking in all B^B^'s tested, to both tumor
and intact virus. On the other hand, both anti-viral and
2 2anti-tumor immunity was detected at 12 days PI in B B 's.
This suggests either a general immune paralysis of tumorous 
5 5B<B-^  hosts, or a specific repression of the immune system by 
suppressor cells. Since humoral anti-viral immunity did 
ultimately develop in B^B^'s (20 days PI), suppressor activity 
may have delayed the immune response in this genotype. Un­
fortunately, three experiments performed according to Greene 
(personal communication) failed to detect suppression of the
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2 5 5 5anti-tumor immunity of B chickens into which B<B^ lympho­
cytes had been adoptively transferred.
5) The most likely explanation for the observed 
results (which may or may not be involved in 5 or 4- above)
is that helper virus (RAV-l) infection or transformation
5 5occurs only in cells of B-'B-' hosts, or to a greater ex±ent 
2 2than in B B 's. These cells, or factors produced by them,
then contribute directly to rapid tumor growth, and/or retard
5 5the development of immunity in B-\Er chickens. Since suscept­
ibility to avian leukosis viruses (including RA.V-1) is probably 
limited to bursal cells (Dunlop, personal communication), this 
hypothesis is consistent with the observation of McBride et al. 
(1977) that enhancement of tumor growth required an intact 
bursa.
Further support for this hypothesis comes from the 
work of Meyers and Qualtiere (1977) who showed that congenital 
infection with avian leukosis virus (ALV) resulted in increased 
size, rate of growth, and incidence of progression of RSV 
tumors induced at 3 weeks of age. In that study, ALV-infected 
animals had normal amounts of antibody to both virus and tumor 
antigens. This is important in light of results reported in 
this thesis, and the fact that the earliest cytopathic effects 
of ALV in vitro require 30 days to develop (Purchase et al.,
197 7 ) • Histopathological changes in vivo have an even longer 
(100 days) latency period. Since the majority of B^B^ birds 
died by 28 days PI, enhancement of tumor growth (regardless of 
mechanism) if present, must be an early consequence of leukosis 
infection (or transformation).
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Whether or not such enhancement is specific to RSV- 
5 5induced, tumors in IKEr hosts might easily he determined hy 
studying the effect of RSV-induced tumorigenesis in one wing 
on the development of an unrelated tumor in the second wing. 
Clearly, additional investigation will he required to dis­
tinguish the effects of RSV from its helper virus, RAV.
ANTI-TUMOR IMMUNITY OF B2B2 CHICKENS 
2
The B haplotype of RPRL chicken lines 6-^ and 6^ is 
clearly associated with rapid development of immunity to sub­
group A RSV-induced tumors. Tumor regression was consistently 
2 2observed in B B chickens hy Collins et al. (1977) a-Hd- in the
present study. This study has confirmed that regression is
due to anti-tumor immunity, since secondary tumors failed to
become established, and many animals had virus-neutralizing
2 2antibody. The thirteen B B chickens which died with a
P Pprogressing tumor (7-1% of all B B 's tested) may have been 
immunologically compromised from endemic diseases perhaps 
including congenital ALV infection. It is clear that 10 of 
these 13 cases occurred during an outbreak of aplastic anemia.
FAILURE OF SECONDARY CHALLENGE TO 
ENHANCE PRIMARY TUMOR GROWTH
The increased growth rate of primary tumors after a 
second virus-inoculation, as reported by McBride et al. (1977)? 
was not observed in this study. The discrepancy is probably 
because these investigators compared the size of left wing 
tumors in birds with either large (both wings.inoculated on
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day 0) or small (second wing inoculated on day 8) right wing 
tumors. The tumor load in the former animals was much higher 
than in the latter, which may have resulted in slower growth 
of the measured tumor in the former (day 0) animals. The 
present study indicated no enhanced growth of primary tumors 
in animals inoculated in the second wing, compared with the 
normal rate of growth in animals with a single tumor.
ELEVATED BED FLUORESCENCE OP LEUKOCYTES FROM 
HOSTS WITH PROGRESSIVE TUMORS
Cucchiara (1976) reported an increase in the number 
of acridine orange stained lymphocytes which fluoresced red 
concomitant with tumor development. Since all lymphocytes 
contain BHA, his procedure apparently lacked the sensitivity 
required to detect low intensity red fluorescence present in 
all cells. The method of Darzynkiewicz et al_. was subsequently 
used, and showed all cells to fluoresce red, some more than 
others.
While more cells with bright red fluorescence were 
observed in tumorous than in control animals, manual counting 
of cells was subjective and very variable. Acridine orange 
stained cells were therefore analyzed in an automated cyto- 
photometer, which objectively measured fluorescence intensities 
of individual cells. The results indicated that, indeed, 
tumorous animals had an increase in the number of peripheral 
leukocytes with bright red fluorescence. These leukocytes 
were apparently lymphocytes, since they were mononuclear, non­
adherent, and agranulocytic, and were found in the lymphocyte
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peak of histograms from automated cytophotometry. That as 
many as 40% of leukocytes had bright red fluorescence, while 
more than 80% of cells analyzed were either thrombocytes or 
lymphocytes, also supports this conclusion.
Cells with bright red fluorescence have an increased 
ENA content (Darzynkiewicz et_ al., 1976) associated with ENA 
and protein synthesis. In tumor birds, this may be indicative 
of active suppressor cells, virus infected, or transformed 
cells. Since peripheral leukocyte preparations from animals 
with large tumors produced sarcomas in susceptible chicks, 
with a latent period shorter than that for virus (unpublished 
results), transformed cells were apparently present in 
peripheral blood. Since these red fluorescing cells were not 
removed by monolayering, they were apparently not fibroblasts, 
and probably represented either virus-infected or transformed 
lymphocytes. They may be involved in non-specific immuno­
suppression, suppression specifically directed at anti-tumor 
immunity or in the production of tumor enhancing (growth) 
factors.
NUCLEIC ACID BELEASED BY WASHING
Cucchiara (1976) associated loss of red fluorescence 
after washing of lymphocytes with the appearance in washes of 
ENA. He was able to wash absorbing material from lympho­
cytes of tumor-bearing birds only. However, he did not monitor 
cell viability or numbers subsequent to repeated washes.
In experiments with both splenic and peripheral 
lymphocytes, the present results indicate loss of up to 47%
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of cells after three washes. -^ 260 ma^e;r;i-al was found in
washes from both normal and tumor-bearer lymphocytes, in 
complete disagreement with Cucchiara, and probably represented 
intracellular nucleic acid liberated by cell-lysis.
SUTiMRY
Cells (probably lymphocytes) with elevated RNA levels 
were detected in the peripheral blood of chickens with large 
RSV-induced tumors and probably represented infected or 
transformed cells. This agreed with the finding that chickens 
susceptible to progressive tumors (B^B^ genotype) appeared 
to be immunologically impaired following, but not prior to,
p p
tumor induction. Chickens of the regressor genotype (B B ) 
had functional immunity at 10-12 days PI since they resisted 
a second virus challenge and usually had virus-neutralizing 
activity in their sera. That not all tumor-resistant animals 
had detectable anti-viral antibody suggested that immunity to 
RSV-induced tumors was not antibody dependent.
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APPENDIX
I. Diluent for Virus
A. Pormula
Hanks ‘balanced ’salt solution (GIBCO)
Petal calf serum (GIBCO)...........
Penicillin (GIBCO), 10,000 u/ml....








The above sterile ingredients were mixed aseptic- 
ally and the diluent stored in 50 ml aliquots at
II. Picoll Diatrizoate
A. Pormula
24 parts of 9% (w/v) Picoll (m.w. 40,000; Sigma)
15 parts of 35-9% (w/v) hypaque brand sodium 
diatrizoate (Winthrop)
B. Preparation
Ficoll and hypaque stocks were prepared separately, 
mixed, distributed into glass bottles, and auto- 
claved at 110 C for 30 mih. Specific gravity was 





III. Glutaraldehyde Fixative for Acridine Orange Staining
A. Formula
NaH2P04 (2.26% w/v; Baker)...............  96.2 ml
UaOH (2.52% w/v; Baker)..................  3-8 ml
Glutaraldehyde (25% w/v; EMS)  18.0 ml
B. Preparation
Stock solutions of sodium phosphate and sodium 
hydroxide were stored at 4 C for up to 3 months. Salts 
were mixed, glutaraldehyde was added, and fixative 
was stored tightly sealed for up to 1 month.
IV. Natt-Herrick Stain
A. Formula
NaCl (Baker).............................  3*88 g
Na2S04 (Baker)...........................  2.50 g
Na2HP0^ _ (Baker)..........................  1.15 g
KH2P04 (Baker)...................... 0.25 g
Formalin (37%)  7*50 ml
Methyl violet 2B (Baker).................  0.10 g
B. Preparation
The above chemicals were dissolved in distilled 
water in the order listed and diluted to a total 
volume of 1,000 ml. After standing overnight, the 
solution was filtered through Whatman no. 2 paper, 
and was ready for use. .The stain was stored at 
room temperature in the dark for up to 1 year.
C. Use
Cells were diluted 1:10 or 1:100 into stain, shaken 
for 1 min, and observed in a wet mount preparation.
